Fluorouracil modulation in head and neck cancer.
Vokes
E E
EE
Department of Medicine and Radiation Oncology, University of Chicago Medical Center, IL 60637-1470.
D000493:Allopurinol / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D008727:Methotrexate / Q000031:analogs & derivatives / Q000627:therapeutic use
D007155:Immunologic Factors; D000493:Allopurinol; D007372:Interferons; D002955:Leucovorin; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate